CN102038758B - Rheumatism preparation used for treating rheumatism - Google Patents
Rheumatism preparation used for treating rheumatism Download PDFInfo
- Publication number
- CN102038758B CN102038758B CN201110001032XA CN201110001032A CN102038758B CN 102038758 B CN102038758 B CN 102038758B CN 201110001032X A CN201110001032X A CN 201110001032XA CN 201110001032 A CN201110001032 A CN 201110001032A CN 102038758 B CN102038758 B CN 102038758B
- Authority
- CN
- China
- Prior art keywords
- rheumatism
- radix
- parts
- preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 239000009636 Huang Qi Substances 0.000 claims abstract description 21
- 241001251068 Formica fusca Species 0.000 claims description 35
- 241000131808 Scolopendra Species 0.000 claims description 25
- 241000522620 Scorpio Species 0.000 claims description 25
- 241000190633 Cordyceps Species 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 14
- 239000009490 scorpio Substances 0.000 claims description 14
- 241000255791 Bombyx Species 0.000 claims description 13
- 241000903946 Clematidis Species 0.000 claims description 13
- 241000218176 Corydalis Species 0.000 claims description 13
- 241001489978 Eupolyphaga Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 13
- 240000000599 Lentinula edodes Species 0.000 claims description 13
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 13
- 241000283956 Manis Species 0.000 claims description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 13
- 241000180649 Panax notoginseng Species 0.000 claims description 13
- 241000237636 Pheretima Species 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 24
- 230000036407 pain Effects 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 14
- 210000000988 bone and bone Anatomy 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 238000005728 strengthening Methods 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 9
- 210000003205 muscle Anatomy 0.000 abstract description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 241000257303 Hymenoptera Species 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000013543 active substance Substances 0.000 abstract description 3
- 206010003246 arthritis Diseases 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 37
- 239000003814 drug Substances 0.000 description 18
- 206010039073 rheumatoid arthritis Diseases 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 210000004247 hand Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 238000004062 sedimentation Methods 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 241001523579 Ostrea Species 0.000 description 5
- 241000545442 Radix Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000000812 cholinergic antagonist Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000003811 finger Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000012744 reinforcing agent Substances 0.000 description 4
- 230000002048 spasmolytic effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010039710 Scleroderma Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 208000010183 Thymus Hyperplasia Diseases 0.000 description 3
- 206010047124 Vasculitis necrotising Diseases 0.000 description 3
- 206010048222 Xerosis Diseases 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000001145 finger joint Anatomy 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 206010025135 lupus erythematosus Diseases 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028289 Muscle atrophy Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 206010065159 Polychondritis Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 201000002661 Spondylitis Diseases 0.000 description 2
- 201000009594 Systemic Scleroderma Diseases 0.000 description 2
- 206010042953 Systemic sclerosis Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002269 analeptic agent Substances 0.000 description 2
- 230000003555 analeptic effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000004704 glottis Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010008685 Chondritis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
- 235000016838 Pomo dAdamo Nutrition 0.000 description 1
- 244000003138 Pomo dAdamo Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000003782 Raynaud disease Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010040825 Skin depigmentation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- -1 brown Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000003797 carpal joint Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000003685 cricoid cartilage Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000009748 deglutition Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000037451 immune surveillance Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000009169 relapsing polychondritis Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000003131 sacroiliac joint Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a rheumatism preparation used for treating rheumatism, mainly solving the technical problems of treating both principal and secondary aspects of rheumatism, especially rheumatism arthritis, and causing rheumatism to be difficult to relapse after healing. The rheumatism preparation comprises the following components in parts by weight: 1-5000 parts of ants, 1-30 parts of scorpions, 1-500 parts of centipedes, 5-500 parts of radix astragali, 1-1000 parts of salvia miltiorrhiza, 1-300 parts of cortex acanthopanacis, 1-100 parts of tree peony bark and 1-100 parts of szechuan lovage rhizome. Compared with the prior art, the rheumatism preparation has the functions of tonifying liver and kidney, strengthening muscles and bones, replenishing qi and blood, expelling wind and removing dampness, reducing phlegm and removing blood stasis as well as dredging collaterals and relieving pain. While remaining all the active ingredients and active substances of the ant raw material, the preparation provided by the invention is directly absorbed and utilized by the human bodies in the form of enzyme, so that the absorption and utilization ratio is improved to more than 80% from 20%, and the preparation bidirectionally regulates the immunity, strengthens body resistance to eliminate pathogenic factors and simultaneously treats different diseases, thus radically achieving the aim of comprehensively treating rheumatism.
Description
Technical field
The present invention relates to a kind of rheumatism preparation, the rheumatismal rheumatism preparation of particularly a kind of treatment.
Background technology
Rheumatismal novel concept be meant institute ill in the joint, bone, cartilage, synovial bursa, tendon and muscle and skin, show as one group of disease crowd of pain, belong to Chinese medicine " arthromyodynia " category.Comprise: connective tissue disease such as rheumatoid arthritis, rheumatic fever, lupus erythematosus, scleroderma, dermatomyositis, necrotizing vasculitis and other angiopathy, dry syndrome, overlapping syndrome, polymyalgia rheumatica, erythema nodosum, relapsing polychondritis.Arthritis relevant such as mandatory spondylitis with spondylitis.Degeneration property joint disease such as osteoarthritis, osteoarthritis, proliferative arthritis.Rheumatism is the chronic commonly encountered diseases of serious harm human health, and sickness rate accounts for the 12-20% of population, the part be difficult disease such as the rheumatoid arthritis that present world medicine is not captured as yet, its 80% with EB (Epstein-Barr virus; EBV) viral infection is relevant, is commonly called as one of four big incurable diseases, and it can make the people disable, disability, even threat to life.The medicine of prior art can only improve symptom, is difficult to radical cure, and a series of side effect can occur, might cause its disease.
Summary of the invention
The purpose of this invention is to provide the rheumatismal rheumatism preparation of a kind of treatment, the technical problem that solve is to rheumatism disease rheumatoid arthritis particularly, reaches treating both the principal and secondary aspects of a disease, and more the back is difficult for recurrence.
The present invention adopts following technical scheme: the rheumatismal rheumatism preparation of a kind of treatment, contain following weight ratio ingredient:
Formica fusca 1-5000, Scorpio 1-30, Scolopendra 1-500,
Radix Astragali 5-500, Radix Salviae Miltiorrhizae 1-1000, Cortex Acanthopancis 1-300,
Cortex Moutan 1-100, Rhizoma Chuanxiong 1-100.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Zaocys 2-50, Herba Epimedii 5-100, Bombyx Batryticatus 5-100,
Squama Manis 2-30, Flos Chrysanthemi 1-100, Pheretima 5-80,
Rhizoma Smilacis Glabrae 5-100, eupolyphaga 1-100, Concha Ostreae 5-300,
Rhizoma Atractylodis 5-100, windproof 1-100, Radix Clematidis 1-500,
Cortex Lycii 1-200, Radix Notoginseng 1-500, Radix Rehmanniae 2-300,
Ramulus Cinnamomi 5-100, Radix Glycyrrhizae 1-100, Cordyceps 0.1-50,
Radix Achyranthis Bidentatae 5-200, Rhizoma Corydalis 1-100, Radix Angelicae Sinensis 1-200,
Lentinus Edodes 0.1-30.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Formica fusca 10-300, Scorpio 2-15, Scolopendra 10-150,
Radix Astragali 5-160, Radix Salviae Miltiorrhizae 10-150, Cortex Acanthopancis 5-80,
Cortex Moutan 2-50, Rhizoma Chuanxiong 3-50.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Zaocys 5-35, Herba Epimedii 6-65, Bombyx Batryticatus 10-30,
Squama Manis 2-10, Flos Chrysanthemi 5-60, Pheretima 10-40,
Rhizoma Smilacis Glabrae 5-60, eupolyphaga 5-60, Concha Ostreae 10-160,
Rhizoma Atractylodis 5-60, windproof 2-30, Radix Clematidis 2-250,
Cortex Lycii 3-120, Radix Notoginseng 4-50, Radix Rehmanniae 5-70,
Ramulus Cinnamomi 5-56, Radix Glycyrrhizae 1-60, Cordyceps 0.5-12,
Radix Achyranthis Bidentatae 5-60, Rhizoma Corydalis 2-50, Radix Angelicae Sinensis 5-60,
Lentinus Edodes 1-20.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Formica fusca 168, Scorpio 2, Scolopendra 2.5,
The Radix Astragali 20, Radix Salviae Miltiorrhizae 30, Cortex Acanthopancis 16,
Cortex Moutan 6, Rhizoma Chuanxiong 10.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Zaocys 24, Herba Epimedii 18, Bombyx Batryticatus 20,
Squama Manis 2, Flos Chrysanthemi 8, Pheretima 20,
Rhizoma Smilacis Glabrae 16, eupolyphaga 20, Concha Ostreae 30,
Rhizoma Atractylodis 14, windproof 6, Radix Clematidis 6,
Cortex Lycii 10, Radix Notoginseng 10, the Radix Rehmanniae 16,
Ramulus Cinnamomi 14, Radix Glycyrrhizae 4, Cordyceps 2,
Radix Achyranthis Bidentatae 20, Rhizoma Corydalis 6, Radix Angelicae Sinensis 20,
Lentinus Edodes 1.6.
The rheumatismal rheumatism preparation of a kind of treatment, contain following weight ratio ingredient:
Formica fusca 1-10000, Scorpio 0.1-3000, Scolopendra 0.1-3000,
Radix Astragali 1-5000, Radix Salviae Miltiorrhizae 1-5000, Cortex Acanthopancis 1-5000,
Cortex Moutan 1-5000, Rhizoma Chuanxiong 1-5000.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Formica fusca 10-5000, Scorpio 0.5-1500, Scolopendra 1-1800,
Radix Astragali 10-3000, Radix Salviae Miltiorrhizae 10-3500, Cortex Acanthopancis 10-3000,
Cortex Moutan 10-3500, Rhizoma Chuanxiong 10-3500.
The rheumatismal rheumatism preparation of treatment of the present invention contains following weight ratio ingredient:
Formica fusca 1333, Scorpio 222, Scolopendra 89,
The Radix Astragali 133, Radix Salviae Miltiorrhizae 111, Cortex Acanthopancis 111,
Cortex Moutan 111, Rhizoma Chuanxiong 111.
The present invention compared with prior art has the effect of invigorating the liver and kidney, bone and muscle strengthening, replenishing QI and blood, expelling wind and removing dampness, the removing blood stasis that reduces phlegm, removing obstruction in the collateral to relieve pain, is wide spectrum immune function reinforcing agent; Leukocyte and lysozyme in the blood are increased; Improve the huge function of biting, thereby promote the effect of nonspecific immunity defense system, improve quantity and blood antibody horizontal that antigen triggers back specific antibody cellulation; In whole effective ingredient that kept the Formica fusca raw material and active substance while; Form with enzyme is directly absorbed by body, and absorption rate is brought up to more than 80% from 20%, on the basis in invigorating the liver and kidney, bone and muscle strengthening, dispelling cold and dampness, the meridian dredging, sharp joint, reaches two-ways regulation immunity; Strengthening vital QI to eliminate pathogenic factors, treating different diseases with the same therapeutic principle fundamentally reach the rheumatismal purpose of Comprehensive Treatment.
The specific embodiment
Below in conjunction with embodiment the present invention is done further explain.The rheumatismal rheumatism preparation of treatment of the present invention is a unit with the gram, is made up of following weight ratio ingredient:
Formica fusca 1-5000 Zaocys 2-50 Herba Epimedii 5-100
Squama Manis 2-30 Flos Chrysanthemi 1-100 Pheretima 5-80
Bombyx Batryticatus 5-100 Scorpio 1-30 Scolopendra 1-500
Rhizoma Smilacis Glabrae 5-100 eupolyphaga 1-100 Concha Ostreae 5-300
Rhizoma Atractylodis 5-100 Cortex Moutan 1-100 Radix Astragali 5-500
Cortex Lycii 1-200 Radix Notoginseng 1-500 Radix Rehmanniae 2-300
The windproof 1-100 of Ramulus Cinnamomi 5-100 Rhizoma Chuanxiong 1-100
Radix Achyranthis Bidentatae 5-200 Rhizoma Corydalis 1-100 Radix Angelicae Sinensis 1-200
Lentinus Edodes 0.1-30 Radix Salviae Miltiorrhizae 1-1000 Cortex Acanthopancis 1-300
Radix Glycyrrhizae 1-100 Cordyceps 0.1-50 Radix Clematidis 1-500.
The rheumatismal rheumatism preparation of treatment of the present invention is a unit with the gram, is made up of following preferred weight ratio component:
Formica fusca 10-300 Zaocys 5-35 Herba Epimedii 6-65
Squama Manis 2-10 Flos Chrysanthemi 5-60 Pheretima 10-40
Bombyx Batryticatus 10-30 Scorpio 2-15 Scolopendra 10-150
Rhizoma Smilacis Glabrae 5-60 eupolyphaga 5-60 Concha Ostreae 10-160
Rhizoma Atractylodis 5-60 Cortex Moutan 2-50 Radix Astragali 5-160
Cortex Lycii 3-120 Radix Notoginseng 4-50 Radix Rehmanniae 5-70
The windproof 2-30 of Ramulus Cinnamomi 5-56 Rhizoma Chuanxiong 3-50
Radix Achyranthis Bidentatae 5-60 Rhizoma Corydalis 2-50 Radix Angelicae Sinensis 5-60
Lentinus Edodes 1-20 Radix Salviae Miltiorrhizae 10-150 Cortex Acanthopancis 5-80
Radix Glycyrrhizae 1-60 Cordyceps 0.5-12 Radix Clematidis 2-250.
The rheumatismal rheumatism preparation of treatment of the present invention is a unit with the gram, is made up of following optimum weight ratio component:
Formica fusca 168 Zaocyss 24 Herba Epimedii 18
Squama Manis 2 Flos Chrysanthemis 8 Pheretimas 20
Bombyx Batryticatus 20 Scorpios 2 Scolopendras 2.5
Rhizoma Smilacis Glabrae 16 eupolyphaga 20 Concha Ostreaes 30
Rhizoma Atractylodis 14 Cortex Moutans 6 Radixs Astragali 20
Cortex Lycii 10 Radix Notoginseng 10 Radix Rehmanniae 16
Ramulus Cinnamomi 14 Rhizoma Chuanxiongs 10 windproof 6
Radix Achyranthis Bidentatae 20 Rhizoma Corydalis 6 Radix Angelicae Sinensis 20
Lentinus Edodes 1.6 Radix Salviae Miltiorrhizaes 30 Cortex Acanthopanciss 16
Radix Glycyrrhizae 4 Cordycepses 2 Radix Clematidis 6.
The rheumatismal rheumatism preparation of treatment of the present invention, the rheumatism preparation of particularly treating rheumatoid arthritis RA is a unit with the gram, is made up of following weight ratio ingredient:
Formica fusca 1-10000 Scorpio 0.1-3000 Scolopendra 0.1-3000
Radix Astragali 1-5000 Radix Salviae Miltiorrhizae 1-5000 Cortex Acanthopancis 1-5000
Cortex Moutan 1-5000 Rhizoma Chuanxiong 1-5000.
The rheumatismal rheumatism preparation of treatment of the present invention, the rheumatism preparation of particularly treating rheumatoid arthritis RA is a unit with the gram, is made up of following preferred weight ratio component:
Formica fusca 10-5000 Scorpio 0.5-1500 Scolopendra 1-1800
Radix Astragali 10-3000 Radix Salviae Miltiorrhizae 10-3500 Cortex Acanthopancis 10-3000
Cortex Moutan 10-3500 Rhizoma Chuanxiong 10-3500.
The rheumatismal rheumatism preparation of treatment of the present invention, the rheumatism preparation of particularly treating rheumatoid arthritis RA is a unit with the gram, is made up of following optimum weight ratio component:
Formica fusca 1333 Scorpios 222 Scolopendras 89
The Radix Astragali 133 Radix Salviae Miltiorrhizaes 111 Cortex Acanthopanciss 111
Cortex Moutan 111 Rhizoma Chuanxiongs 111.
The rheumatismal rheumatism preparation of treatment of the present invention, the effect and the effect of the Chinese medicine of respectively distinguishing the flavor of that is adopted:
Ants, with nourishing liver and kidney, nourishing Qi, fill impotence, gluten bone health, Qufeng role, Ming Li, "Compendium of Materia Medica" in an article written: ants everywhere ...... their eggs in the name Qi, mountains people dig it, the ancients eat, it is within.The bean that heavenly officials present food has fish or meat paste also: ordinary person eats it, QI invigorating pool face. the person's of dying food and heal also.Experiment showed, that through pharmacological research ant extract is a broad-spectrum immune function reinforcing agent.Outstanding behaviours increases for making aged Mus blood leucocyte and lysozyme, improves macrophage phagocytic function, thereby has promoted the effect of nonspecific immunity defense system; Can improve quantity and serum antibody level that antigen triggers back specific antibody cellulation; Simultaneously from making EaRFC, E
1RFC, ANAE positive cell and lymphocyte absolute value raise, and can find out that ant liquid is again a kind of cellular immunization analeptic.The root that involution of thymus and the cellular immunization underactivity, immunoregulation and the immune surveillance hypofunction that cause therefrom are old and feeble and infection, tumor, autoimmune disease take place.And thymic hyperplasia, weight that ant liquid can make aged Mus become to degenerating increase, cortical areas's lymphocytosis, and the interior DNA of PBLC, rna content and motherization cell rate are increased, and this is the result that ant liquid directly promotes immune maincenter functional activation.The M of aged Mus blood of injection ant liquid group and immune organ
n, S
e, Z
nContent obviously rises, and C
U, F
EContent reduces, and this change also is one of major reason of defying age, enhance immunity.Formica fusca can be improved the erythrocyte vigor, lowers blood fat, promotes immunologic function, plays the effect that hepatoprotective, calmness, antiinflammatory, analgesia and spasmolytic are relievingd asthma, and is all effective in cure to moving diseases such as liver, chronic hepatitis, hyperlipidemia, neurasthenia, diabetes, quasi-wind gateway, asthma.The Formica fusca body contains 19 seed amino acids such as threonine, phenylalanine, valine, methionine, lysine, and comprising 8 seed amino acids of needed by human, protein content is up to 40-60%; And contain vitamin B
1, B
2, B
3, C, D, E etc.; Trace element contains 28 kinds of zinc, ferrum, selenium, phosphorus, calcium etc., and wherein 14 kinds is needed by human body, and especially zinc, selenium (flower of life, immunity this) content is the abundantest, than the high 10-20 of any food of nature doubly, also contains Fructus Citri Limoniae (C
10H
14O), formaldehyde (HCHO), breast formaldehyde (C
10H
14O) special defects chemical compound such as citral; Also contain bioactive substances such as ATP, plurality of enzymes and auxilliary acid, alkaloid, histamine; Also having special (Formica fusca antibiotic) here is extraordinary antibiotics such as metathorax side pole parathyrine, therefore is known as microfauna nutrition treasure-house.
Scorpio has wind-expelling pain-stopping, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain effect.
Scolopendra has endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain effect.
Radix Salviae Miltiorrhizae has stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, and the relieving restlessness effect that clears away heart-fire can suppress platelet and discharge the vasoconstrictive material, reduces thromboxane A
2Release, in vitro tests has anticoagulant effect.
The Radix Astragali, tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, the detoxification granulation promoting, inducing diuresis to remove edema is mended the gas of the whole body, can strengthen the T cell function, again can the extension body cell survival, have the anti-ageing effect of lengthening the life, its extracting section thing can improve mice plasma
cAMP content, thus immunologic balance regulated, quicken lymphocyte transformation, increase the T cell function, can also suppress the immune disease that autoantibody causes.
Cortex Acanthopancis has wind-damp dispelling, invigorating the liver and kidney; The bone and muscle strengthening effect; Being immunopotentiating agent, also is immunomodulator, and immune organ is promoted and protective effect with organizing; Extract can promote mice spleen and thymic hyperplasia, thereby suitable place is provided for T cell and the maturation of B cell and the performance of differentiation and function thereof.
Cortex Moutan, blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, the paeonol in zoopery proof Cortex Moutan have calmness, hypnosis, bring down a fever, antiinflammatory, reduction vascular permeability, eliminate the effect of sufficient edema.
Rhizoma Chuanxiong, blood-activating and qi-promoting, wind-expelling pain-stopping, its decoct ability coronary artery dilator strengthens flow coronarius, improves blood supply of cardiac muscle and reduces the myocardial oxygen consumption effect.
Cordyceps has the effect of invigorating the lung and the kidney, hemostasis and phlegm, is used for the chronic cough dyspnea due to deficiency, chronic cough spitting of blood, impotence and seminal emission, soreness of waist and knee joint." Bencao Congxin " record Cordyceps " protects the lung kidney tonifying, hemostasis and phlegm, chronic cough "." property of medicine is examined " record " secret lean gas is specially mended the gate of vitality ".
Ramulus Cinnamomi, relieving the exterior syndrome by diaphoresis, warming the meridian for promoting the flow of YANG QI.
Windproof, expelling pathogenic wind from the body surface wins and wets, pain relieving, spasmolytic.
Flos Chrysanthemi is returned liver, lung meridian, wind and heat dispersing, and detoxifcation makes eye bright.
Rhizoma Smilacis Glabrae has detoxifcation, dehumidifying, the effect in sharp joint.
The Cortex Lycii removing heat from blood moves back steaming, eliminating heat from the lung.
Rhizoma Atractylodis, have drying damp and strengthening spleen, wind-damp dispelling.
Radix Notoginseng has removing stasis to stop bleeding, the effect of the analgesic therapy of invigorating blood circulation.
Radix Achyranthis Bidentatae has blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, the effect of conducting blood to flow downwards.
Squama Manis has promoting blood circulation to restore menstrual flow, stimulating milk secretion, the effect of detumescence and apocenosis.
Concha Ostreae has suppressing the hyperactive liver and subsiding YANG, and hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweating effect.
Bombyx Batryticatus has the endogenous wind stopping relieving convulsion, wind-expelling pain-stopping, the effect of detoxicating and resolving stagnation of pathogens.
Pheretima has clearing heat for calming endogenous wind, relievings asthma collateral dredging, diuretic effect.
The Radix Glycyrrhizae invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, relieving spasm to stop pain relaxes the property of medicine.
Chinese angelica blood supplementing is invigorated blood circulation, pain relieving, intestine moistening.
Radix Rehmanniae clearing away heat and cooling blood, Feng is given birth in yin nourishing.
The Radix Clematidis wind-damp dispelling, the meridian dredging, stopping numbness pain is controlled a fishbone or other bone caught in the throat.
The Zaocys nature and flavor are sweet flat, nontoxic, dispel the wind, and are active, arresting convulsion.
The eupolyphaga removing blood stasis, reunion of fractured tendons and bones.
Herba Epimedii has another name called Herba Epimedii, has kidney invigorating and YANG supporting, the expelling wind and removing dampness effect.
Rhizoma Corydalis is invigorated blood circulation, circulation of qi promoting, pain relieving.
Lentinus Edodes has the tonify deficiency of setting upright, spleen benefiting and stimulating the appetite, the rash of dispeling the wind, phlegm-eliminiating and qi-regulating, detoxifcation, anticancer function.
Rheumatism is the difficult miscellaneous diseases that a kind of immune system disorder causes, and belongs to Chinese medicine " arthromyodynia " category.Formica fusca is the in love article of flesh and blood, has replenishing vital essence and invigorating vital QI, and the effect of the flourish muscle of nourishing the liver, blood circulation promoting competent silt, expelling wind and removing dampness has the treatment must aim at the pathogenesis of disease effect to rheumatism, and the internal and external factor that can fundamentally treat the generation of rheumatism pathological changes causes the intractable arthromyodynia.It is monarch drug that compatibility of the present invention is reused Formica fusca.Modern medicine study proves: Formica fusca is that a wide spectrum immune function reinforcing agent is a cellular immunization analeptic, can make rudimentary thymic hyperplasia again simultaneously, directly promotes immune maincenter functional activation.Immunity is dual regulation.Have effects such as antiinflammatory, analgesia, calmness, spasmolytic, rheumatism.Drug matching by traditional Chinese medical science monarch, minister, the principles of formulating prescriptions of helping, making and other 29 flavors is used, and plays treating both the principal and secondary aspects of a disease, and the purpose of cure diseases is fundamentally taken for a long time and had no side effect.And with Formica fusca, Scorpio, Scolopendra flesh and blood by the animal drugs Chinese medicine of the article of essence serve as the main Radix Astragali that is equipped with strengthening vital QI to eliminate pathogenic factors, Radix Salviae Miltiorrhizae, Cortex Acanthopancis, Cortex Moutan, Rhizoma Chuanxiong the classical prescription formed of totally 8 flavor medicines rheumatoid arthritis both taken stopgap measures to effect a permanent cure obtained very good effect clinically.
The rheumatismal rheumatism preparation of treatment of the present invention; Adopt following method to prepare: to press mass ratio; The above Chinese medicine of respectively distinguishing the flavor of is added 10 times of water gagings respectively decoct 3 times, each 1 hour, collecting decoction; Filter, be evaporated to the extractum that relative density is 1.18-1.20 (60 ℃), obtain the rheumatismal rheumatism preparation of treatment of the present invention.
Press mass ratio, every 100gk extractum adds water 65gk, water dissolution, filters, processes liquid, and rheumatismal rheumatism preparation oral liquid obtains medical treatment.
In extractum, adding 90%-98% ethanol to concentration of alcohol is 60%, place more than 12 hours, and the supernatant sucking-off, the precipitate with ethanol suspension is centrifugal, merges alcoholic solution, and decompression recycling ethanol is concentrated into relative density 1.10-1.14 (60 ℃), drying.Process granule, be distributed into packed one-tenth electuary, the rheumatismal rheumatism preparation electuary that obtains medical treatment, or incapsulate, rheumatismal rheumatism preparation capsule obtains medical treatment.
The rheumatismal rheumatism preparation oral of treatment of the present invention liquid is liquid state, sepia, and feeble QI is fragrant, little sweet, the little acid of flavor, and free from extraneous odour supplies orally, uses warm water delivery service, and every day 3 times, each 20 milliliters, 3 months is a course of treatment.
The rheumatismal rheumatism preparation of treatment of the present invention electuary is graininess, and brown, gas delicate fragrance, mildly bitter flavor are used warm boiled water, every day 3 times, and each 3 grams, 3 months is a course of treatment.
The rheumatismal rheumatism preparation of treatment of the present invention capsule, brown, gas delicate fragrance, mildly bitter flavor is used warm water delivery service, every day 3 times, each 3 (every capsules weighs 0.4 gram), 3 months is a course of treatment.
Embodiment 1, and unit is gram,
Formica fusca 1 Zaocys 2 Herba Epimedii 5
Squama Manis 2 Flos Chrysanthemis 1 Pheretima 5
Bombyx Batryticatus 5 Scorpios 1 Scolopendra 1
Rhizoma Smilacis Glabrae 5 eupolyphaga 1 Concha Ostreae 5
Rhizoma Atractylodis 5 Cortex Moutans 1 Radix Astragali 5
Cortex Lycii 1 Radix Notoginseng 1 Radix Rehmanniae 2
Ramulus Cinnamomi 5 Rhizoma Chuanxiongs 1 windproof 1
Radix Achyranthis Bidentatae 5 Rhizoma Corydalis 1 Radix Angelicae Sinensis 1
Lentinus Edodes 0.1 Radix Salviae Miltiorrhizae 1 Cortex Acanthopancis 1
Radix Glycyrrhizae 1 Cordyceps 0.1 Radix Clematidis 1.
Embodiment 2, and unit is gram,
Formica fusca 5000 Zaocyss 50 Herba Epimedii 100
Squama Manis 30 Flos Chrysanthemis 100 Pheretimas 80
Bombyx Batryticatus 100 Scorpios 30 Scolopendras 500
Rhizoma Smilacis Glabrae 100 eupolyphaga 100 Concha Ostreaes 300
Rhizoma Atractylodis 100 Cortex Moutans 100 Radixs Astragali 500
Cortex Lycii 200 Radix Notoginseng 500 Radix Rehmanniae 300
Ramulus Cinnamomi 100 Rhizoma Chuanxiongs 100 windproof 100
Radix Achyranthis Bidentatae 200 Rhizoma Corydalis 100 Radix Angelicae Sinensis 200
Lentinus Edodes 30 Radix Salviae Miltiorrhizaes 1000 Cortex Acanthopanciss 300
Radix Glycyrrhizae 100 Cordycepses 50 Radix Clematidis 500.
Embodiment 3, and unit is gram,
Formica fusca 10 Zaocyss 5 Herba Epimedii 6
Squama Manis 2 Flos Chrysanthemis 5 Pheretimas 10
Bombyx Batryticatus 10 Scorpios 2 Scolopendras 10
Rhizoma Smilacis Glabrae 5 eupolyphaga 5 Concha Ostreaes 10
Rhizoma Atractylodis 5 Cortex Moutans 2 Radixs Astragali 5
Cortex Lycii 3 Radix Notoginseng 4 Radix Rehmanniae 5
Ramulus Cinnamomi 5 Rhizoma Chuanxiongs 3 windproof 2
Radix Achyranthis Bidentatae 5 Rhizoma Corydalis 2 Radix Angelicae Sinensis 5
Lentinus Edodes 1 Radix Salviae Miltiorrhizae 10 Cortex Acanthopanciss 5
Radix Glycyrrhizae 1 Cordyceps 0.5 Radix Clematidis 2.
Embodiment 4, and unit is gram,
Formica fusca 300 Zaocyss 35 Herba Epimedii 65
Squama Manis 10 Flos Chrysanthemis 60 Pheretimas 40
Bombyx Batryticatus 30 Scorpios 15 Scolopendras 150
Rhizoma Smilacis Glabrae 60 eupolyphaga 60 Concha Ostreaes 160
Rhizoma Atractylodis 60 Cortex Moutans 50 Radixs Astragali 160
Cortex Lycii 120 Radix Notoginseng 50 Radix Rehmanniae 70
Ramulus Cinnamomi 56 Rhizoma Chuanxiongs 50 windproof 30
Radix Achyranthis Bidentatae 60 Rhizoma Corydalis 50 Radix Angelicae Sinensis 60
Lentinus Edodes 20 Radix Salviae Miltiorrhizaes 150 Cortex Acanthopanciss 80
Radix Glycyrrhizae 60 Cordycepses 12 Radix Clematidis 250.
Embodiment 5, and unit is gram,
Formica fusca 168 Zaocyss 24 Herba Epimedii 18
Squama Manis 2 Flos Chrysanthemis 8 Pheretimas 20
Bombyx Batryticatus 20 Scorpios 2 Scolopendras 2.5
Rhizoma Smilacis Glabrae 16 eupolyphaga 20 Concha Ostreaes 30
Rhizoma Atractylodis 14 Cortex Moutans 6 Radixs Astragali 20
Cortex Lycii 10 Radix Notoginseng 10 Radix Rehmanniae 16
Ramulus Cinnamomi 14 Rhizoma Chuanxiongs 10 windproof 6
Radix Achyranthis Bidentatae 20 Rhizoma Corydalis 6 Radix Angelicae Sinensis 20
Lentinus Edodes 1.6 Mel 86 Radix Salviae Miltiorrhizaes 30
Cortex Acanthopancis 16 Radix Glycyrrhizaes 4 Cordycepses 2
Radix Clematidis 6.
Embodiment 6, and unit is gram,
Formica fusca 1 Scorpio 0.1 Scolopendra 0.1
The Radix Astragali 1 Radix Salviae Miltiorrhizae 1 Cortex Acanthopancis 1
Cortex Moutan 1 Rhizoma Chuanxiong 1.
Embodiment 7, and unit is gram,
Formica fusca 10000 Scorpios 3000 Scolopendras 3000
The Radix Astragali 5000 Radix Salviae Miltiorrhizaes 5000 Cortex Acanthopanciss 5000
Cortex Moutan 5000 Rhizoma Chuanxiongs 5000.
Embodiment 8, and unit is gram,
Formica fusca 10 Scorpios 0.5 Scolopendra 1
The Radix Astragali 10 Radix Salviae Miltiorrhizaes 100 Cortex Acanthopanciss 100
Cortex Moutan 10 Rhizoma Chuanxiongs 10.
Embodiment 9, and unit is gram,
Formica fusca 5000 Scorpios 1500 Scolopendras 1800
The Radix Astragali 3000 Radix Salviae Miltiorrhizaes 3500 Cortex Acanthopanciss 3000
Cortex Moutan 3500 Rhizoma Chuanxiongs 3500.
Embodiment 10, and unit is gram,
Formica fusca 1333 Scorpios 222 Scolopendras 89
The Radix Astragali 133 Radix Salviae Miltiorrhizaes 111 Cortex Acanthopanciss 111
Cortex Moutan 111 Rhizoma Chuanxiongs 111.
Treatment example 1, Tang so-and-so, the woman, 26 years old, people from Xingning City, Guangdong Province suffered from lupus erythematosus.Often generate heat in the time of 20 years old, unable, two buccals are rubescent, are lupus erythematosus at how tame hospital diagnosis.With heavy dose of hormone such as prednisone 65mg/ day, it is disorderly to be equipped with general metabolisms such as occurring whole body osteoporosis, obesity, hirsutism, edema, menolipsis behind the western medicines in treatment, reach 2 years surplus, the state of an illness increased the weight of gradually afterwards.Take embodiment after 1 year, start working, marry after 1 year zero February, given birth to a boy at present, female, sub-health is very healthy.
Treatment example 2, the Wang, the woman, 67 years old, the Pekinese suffered from dry syndrome.50 years old menolipsis, menopause syndrome is obviously suspicious like irritability, and unstable blood pressure is fixed, is prone to perspire, and occurs xerosis cutis, xerostomia (drink water frequently every day, reach the degree that mouth does not leave cup), joint, general aching after 2 years again, alopecia etc.At Concord Hospital, China-Japan Friendship Hospital, the how tame hospital diagnosis of Xiyuan hospital is dry syndrome; Treat, effect is undesirable, and blood pressure, blood glucose, blood fat, uric acid, cholesterol all raise afterwards; Cyst is arranged in the liver; In gallbladder, the kidney calculus is arranged, patient will take more than 20 kind of medicine in one day, and the state of an illness increases the weight of gradually.Take embodiment 2 back 1 first quarter moon drinking-water and obviously reduce, xerostomia takes a turn for the better, and xerosis cutis alleviates; Xerostomia and xerosis cutis disappear basically after 3 months; Whole body is light after half a year, takes between 1 year half that other diseases all take a turn for the better except that dry syndrome is cured, and follows up a case by regular visits to after 3 years and fully recovers.
Treat routine 3 Wang, the woman, 46 years old, people from Hunan suffered from scleroderma.The patient expresses one's feelings stiff, and women's head-ornaments, thoracic dorsal, abdominal part, the hardening of extremity skin are pushed like leather, and two handss can not be clenched fist, stand up like the bed board shape, and dark tongue quality, fat big, tongue is white, deep-thready pulse.Many tame hospital diagnosis: scleroderma, through failing to respond to any medical treatment 3 years more.Take 2,3 months various sxs of embodiment, basic rehabilitation of in February, 1.
Treat 4 Lu, the man 26 years old, suffers from ankylosing spondylitis.Before 3 years because of the stiff companion's extremities joint in back pain, erythrocyte sedimentation rate 116mm/h, RF (+), the X line shows: two sacroiliac jointes gap is fuzzy, articular surface has the cryptomere that differs in size to destroy Western medicine diagnose: ankylosing spondylitis, tcm diagnosis: rheumatism involving the bone (superintend and direct sky is suffered from a deficiency of the kidney, damp and hot resistance network).Bad when how tame hospitalize fashion, increase the weight of gradually recently.Take embodiment 3 back 1 month pain reliefs, pain disappeared in 3 months, and body movement can be run, play more freely in 1 year 2 months after 8 months, and improved self-confidence, married and gave birth to babies at present.
Treat routine 5 Liu, the man, 26 years old, people from Anhui suffered from polychondritis.Throat pain, cough appear in no obvious inducement before half a year, cough a small amount of white sputum crudum, fail to respond to any medical treatment by pharyngitis, after the wide red and swollen heat pain of auris dextra appears, rubescent, the pain of eyes is diagnosed as wide chondritis of auris dextra and conjunctivitis.Give quiet of dexamethasone and collyrium eye dripping, symptom is alleviated slightly, but drug withdrawal promptly recurs, and stridulates with promptly feeling the tachypnea companion after the activity.Have a medical check-up: breathe hurriedly slightly, the activity postemphasis is inspiratory dyspnea, and the companion is stridulated, no cyanosis, neck surface diffusivity acne property erythra, lower back is dispersed in circular erythema, double eyeball conjunctiva mild hyperaemia, auris dextra wide red and swollen, thicken, touch a tender spot.Trachea is placed in the middle, the plentiful bulge of larynx body, and Adam's apple disappears, slightly tenderness.Neck, chest spiral CT three-dimensional rebuilding show that extensive Soft tissue thickening is narrow under cavum laryngis, the glottis, and thyroid cartilage, cricoid cartilage destroy, and trachea, left and right sides bronchus and pulmonary do not see obviously unusual.Electrocardiogram is the T ripple and changes.The Color Sonography ultrasonic examination by Doppler's method shows that ALMV slightly prolapses, and Tricuspid valve and valve of pulmonary trunk trace backflow, and left chamber contractile function is normal.Erythrocyte sedimentation rate 45mm/h.Extensive swelling, narrow under visible cavum laryngis of electronics laryngoscope and the glottis, the cavum laryngis mucosa is smooth.Take embodiment 4 one courses of treatment (3 months) sx, two the course of treatment symptom disappear basically, each item inspection index is obviously improved after three courses of treatment, back recovery from illness in 1 year half.
Treat routine 6 Wus, the man, 41 years old, people from Shandong suffered from necrotizing vasculitis.Right lower extremity congestion and swelling pain 7 days, 39.5 ℃ of the heat that occurs together have obvious toxemia and liver, change in renal function; Local hospital diagnosis is: necrotizing vasculitis, through in, the western medical treatment DeGrain, take embodiment 4; Body temperature was normal in 3 days; 5 days lower limb rednesses and pain are improved, and a course of treatment, (3 months) patient's symptom disappeared basically, and each item inspection index is normal after two courses of treatment.
Treat routine 7 Huangs, the woman, 52 years old, the Pekinese suffered from systemic sclerosis.The patient in calendar year 2001 do not have obvious cause occur both hands meet cold lose color livid purple, companion's arthralgia of fingers, in local hospital by " Raynaud disease " treatment, poor effect; After occur both hands again and meet the cold livid purple sx that loses color, and engender that whole body skin is swollen, accompany pigmentation firmly, be diagnosed as in Concord Hospital " systemic sclerosis "; Through " Radix Salviae Miltiorrhizae Injection, ligustrazine pin ", the sclerderm spirit, vitamin E treatment is surplus January; Symptom does not have improvement, engenders that distal limbs, skin of face thickening are hard, the interval beginning of shirtfront " V " type depigmentation; Whole body skin-color is dark, and for very, face, extremity, chest, abdominal part skin depth are hard with above the waist; Attach most importance to two upper limb far-ends, both hands refer to meet cold or excited be prone to turn white livid purple, both hands articulations digitorum manus joint stuffiness; The shape of the mouth as one speaks diminishes, and the moderate that lolls is limited; Absent deglutition is unfavorable.Dimly pale tongue, white and thin fur, stringy and tense pulse.Erythrocyte sedimentation rate 52mm/h, ScL-70 is positive.Took embodiment 5,3 months, patient's whole skin pigmentation and depigmentation obviously reduce, and dehisce and the both hands limitation of activity significantly improves, and skin is thick after 6 months disappears firmly, and skin elasticity increases, and check erythrocyte sedimentation rate 21mm/h recovers normal after 1 year.
Treat routine 8 Liu so-and-so, the woman 26 years old, suffers from rheumatoid arthritis.Both hands refer to little arthralgia 1 year, and morning is stiff, RF (rheumatoid factor) 103.5 units, and erythrocyte sedimentation rate is fast, anti-" O " height, PIP, metacarpophalangeal joints, the equal swelling of carpal joint, pain, morning is stiff, and the joint does not have distortion, light red tongue, white and thin fur, stringy pulse.Diagnosis: rheumatoid arthritis, to take embodiment 6, one courses of treatment (3 months) and take a turn for the better, symptom and sign obviously improves after half a year, recovery from illness after 1 year.
Treatment example 9, Lin, the woman, 56 years old, retired teacher suffered from rheumatoid arthritis.Swell and ache because of finger-joint March nineteen ninety; The back finger of getting up morning is stiff, attaches most importance to left hand mother, food, middle finger, goes examination in hospital to find that erythrocyte sedimentation rate is fast, anti-" O " is high, rheumatoid factor is positive; Be diagnosed as rheumatoid arthritis; Medication is the each 10mg of prednisone, three times on the one, the each 20g of piroxicam sheet, once-a-day, and Radix Tripterygii Wilfordii and treatment by Chinese herbs took a favorable turn after 3 months.After bad when going to how tame hospital to continue the treatment fashion again, developed into the finger-joint enlargement afterwards, the amyotrophy of connected valleys place, morning, finger was stretched not opened.Take embodiment 7, early, middle and late each 3 (1.2 gram) is clearly better after one course of treatment 3 months one courses of treatment, and various symptoms disappear basically after half a year, and the finger-joint of enlargement recovers after 1 year, and atrophy muscle recovery in connected valleys place is normal, and examination in hospital each item index is normal.
Treat routine 10 kings so-and-so, the woman 35 years old, suffers from rheumatoid arthritis.Point little joint swelling and pain 2 years, morning is stiff, and pain is very sought medical advice in many ways whenever suffering from cold then; RF (rheumatoid factor) 1020 units, erythrocyte sedimentation rate 91mm/h is diagnosed as rheumatoid arthritis, takes embodiment 8; Treatment took a turn for the better after half a year, was almost recovered in 1 year, followed up a case by regular visits to not recurrence in 2 years.
Treat routine 11 models so-and-so, the woman 42 years old, suffers from rheumatoid arthritis.The whole body bone joint pain, the swelling phenomenon appears in two wrists, two ankle, two knee joint, and arm can not stretch, and both hands are stiff after the getting up early, just take a turn for the better after the activity, can not squat down, and are unable to leave the bed when serious, can't take care of oneself the multi-treatment commentaries on classics of not getting better.Taking embodiment 9, one courses of treatment (3 months) patient's symptom has improvement, and be clearly better half a year; Mental status is good after 1 year; Whole body bone joint pain symptom is eliminated, and two wrists, two ankle, two knee joint swelling phenomenon disappear, and the arm activity freely; Can arrange basic housework such as washing clothes, cook, life can be taken care of oneself fully.
Treat routine 12 Yu so-and-so, man, 47 years old, Hong Kong native; It is surplus to suffer from rheumatoid arthritis 20 years, and often arthralgia is stiff, once takes plurality of Chinese, Western medicine such as the treatment of ibuprofen anti-inflammatory analgetic, clothes back alleviation of pain; But arthroncus, pain heating, 38 ℃-39 ℃ of body temperature; Both hands foods, in, thumb is out of shape, two elbow joinies swell and ache not tensible.Health is become thin.Hemogram: leukocyte 8000, erythrocyte 3,800,000, platelet 340,000, erythrocyte sedimentation rate 45mm/h.Chinese medical discrimination belongs to Sheng in the deficiency-heat, the warm stasis of blood is cloudy stagnates.Posterior joint swelled and ache and alleviated 10,3 months (course of treatment) of taking embodiment, two the course of treatment posterior joint basic disappearance of swelling and ache, treat and was almost recovered in 1 year, existing life is normal basically, follows up a case by regular visits to so far and recurs.
Treating the rheumatism disease with rheumatism preparation of the present invention, is a kind of easy, safety, effect and reliable curative Therapeutic Method.But rheumatism is a general obstinate disease, must take by the course of treatment, just can reach the purpose of Comprehensive Treatment.
The present invention is that primary raw material is equipped with the animals and plants medical material with the Formica fusca; Effect with invigorating the liver and kidney, bone and muscle strengthening, replenishing QI and blood, expelling wind and removing dampness, the removing blood stasis that reduces phlegm, removing obstruction in the collateral to relieve pain; It is wide spectrum immune function reinforcing agent; Leukocyte and lysozyme in the blood are increased, improve the huge function of biting, thereby promote the effect of nonspecific immunity defense system; Can improve quantity and blood antibody horizontal that antigen triggers back specific antibody cellulation; Compare with traditional Ants Wine, Formica fusca powder, Formica fusca oral liquid; The whole effective ingredient and the active substance that have not only kept Formica fusca; And the form with enzyme directly absorbs, and absorption rate is brought up to more than 80% from 20%, on the basis in invigorating the liver and kidney, bone and muscle strengthening, dispelling cold and dampness, the meridian dredging, sharp joint, reaches two-ways regulation immunity; " strengthening vital QI to eliminate pathogenic factors ", " treating different diseases with the same therapeutic principle " fundamentally reach the rheumatismal purpose of Comprehensive Treatment.
The present invention compared with prior art, the treatment rheumatism, particularly rheumatoid arthritis the rheumatism preparation to rheumatism; Particularly rheumatoid arthritis has treating both the principal and secondary aspects of a disease, and consolidating is main ideal effect, and can make joint, the atrophy muscle recovery of modification; Raw material is easy to get, and cost is low, has no side effect; Instant effect can be cured, and does not recur after healing.
Claims (1)
1. treat rheumatismal rheumatism preparation for one kind, form by following weight ratio ingredient:
Formica fusca 5000, Zaocys 50, Herba Epimedii 100,
Squama Manis 30, Flos Chrysanthemi 100, Pheretima 80,
Bombyx Batryticatus 100, Scorpio 30, Scolopendra 500,
Rhizoma Smilacis Glabrae 100, eupolyphaga 100, Concha Ostreae 300,
Rhizoma Atractylodis 100, Cortex Moutan 100, the Radix Astragali 500,
Cortex Lycii 200, Radix Notoginseng 500, the Radix Rehmanniae 300,
Ramulus Cinnamomi 100, Rhizoma Chuanxiong 100, windproof 100,
Radix Achyranthis Bidentatae 200, Rhizoma Corydalis 100, Radix Angelicae Sinensis 200,
Lentinus Edodes 30, Radix Salviae Miltiorrhizae 1000, Cortex Acanthopancis 300,
Radix Glycyrrhizae 100, Cordyceps 50, Radix Clematidis 500.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110001032XA CN102038758B (en) | 2011-01-05 | 2011-01-05 | Rheumatism preparation used for treating rheumatism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110001032XA CN102038758B (en) | 2011-01-05 | 2011-01-05 | Rheumatism preparation used for treating rheumatism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102038758A CN102038758A (en) | 2011-05-04 |
| CN102038758B true CN102038758B (en) | 2012-05-02 |
Family
ID=43905519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110001032XA Active CN102038758B (en) | 2011-01-05 | 2011-01-05 | Rheumatism preparation used for treating rheumatism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102038758B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813778B (en) * | 2012-07-30 | 2015-09-09 | 汤杰杰 | A kind of oral Chinese medicine for the treatment of of arthritis |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362934A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Chinese patent medicine for treating erythema nodosum |
| CN102552585B (en) * | 2012-01-09 | 2013-06-12 | 杨承明 | Medicinal liquor for relaxing tendons and activating collaterals |
| CN102836177B (en) * | 2012-09-13 | 2014-10-01 | 杜晓光 | Traditional Chinese medicine preparation for treating osteopathia |
| CN104435699B (en) * | 2013-09-12 | 2018-06-15 | 钱得方 | A kind of Chinese medicinal capsule of systemic lupus erythematosus and preparation method thereof |
| CN104224903A (en) * | 2014-09-24 | 2014-12-24 | 卢卫平 | Wuchong arthralgia-removing analgesic powder |
| CN104491795A (en) * | 2014-12-16 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN106074987A (en) * | 2015-05-31 | 2016-11-09 | 蔡重凯 | Ginseng returns snakes and scorpions wine |
| CN108524864A (en) * | 2018-01-29 | 2018-09-14 | 王学奎 | A kind of traditional Chinese medicine pill for treating the diseases such as cervical spondylosis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1254584A (en) * | 1999-03-16 | 2000-05-31 | 陈柏林 | Ant-scorpion pill for treating pain and numbness |
-
2011
- 2011-01-05 CN CN201110001032XA patent/CN102038758B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1254584A (en) * | 1999-03-16 | 2000-05-31 | 陈柏林 | Ant-scorpion pill for treating pain and numbness |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813778B (en) * | 2012-07-30 | 2015-09-09 | 汤杰杰 | A kind of oral Chinese medicine for the treatment of of arthritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102038758A (en) | 2011-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038758B (en) | Rheumatism preparation used for treating rheumatism | |
| CN102631649B (en) | Method for preparing traditional Chinese medicine (TCM) for treating kidney-Yang deficiency type colitis | |
| CN104367911A (en) | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN102772704A (en) | Medicament for treating geriatric disease | |
| CN103931846A (en) | Health care tea capable of reducing uric acid | |
| CN103223131B (en) | Liver disease drug | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
| CN102145127A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN1234401C (en) | Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule | |
| CN104524174A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof | |
| CN103330837A (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
| CN103705870A (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN103263629A (en) | Medical wine and preparation method thereof | |
| CN105477619A (en) | Traditional Chinese medicine composition for treating delayed menorrhea | |
| CN104606469A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104147277A (en) | Traditional Chinese medicinal preparation for treating myasthenia gravis and preparation method | |
| CN103816403A (en) | Chinese medicinal composition for treating syndrome of deficiency of liver blood | |
| CN102389545A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN104707031A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
| CN105327024A (en) | Traditional Chinese medicine preparation for treating rheumatoid arthritis | |
| CN104547084A (en) | Medicinal liquor for treating rheumatic arthritis and relaxing tendons and activating collaterals and preparation method thereof | |
| CN105194241A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENZHEN RIYUESHEN SCIENCE AND TECHNOLOGY CO., LTD Free format text: FORMER OWNER: YIN GUANGQUAN Effective date: 20120809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518026 SHENZHEN, GUANGDONG PROVINCE TO: 518129 SHENZHEN, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120809 Address after: 518129, Guangdong province Shenzhen Longgang District Bantian street two Hao sun god biopharmaceutical factory Patentee after: Shenzhen sun god Technology Co., Ltd. Address before: 518026 Guangdong city of Shenzhen province Futian District Whampoa court Cui Liu Park Patentee before: Yin Guangquan |